Trial record 1 of 6 for: "Pure Autonomic Failure" | "Norepinephrine"
Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) (NETAF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02784535|
Recruitment Status : Recruiting
First Posted : May 27, 2016
Last Update Posted : August 21, 2019
Vanderbilt University Medical Center
NYU Langone Health
Information provided by (Responsible Party):
Cyndya Shibao, Vanderbilt University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||July 2020|
|Estimated Study Completion Date :||December 2020|
Ramirez CE, Okamoto LE, Arnold AC, Gamboa A, Diedrich A, Choi L, Raj SR, Robertson D, Biaggioni I, Shibao CA. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014 Dec;64(6):1235-40. doi: 10.1161/HYPERTENSIONAHA.114.04225. Epub 2014 Sep 2.